临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (5): 385-390.

• 论著 •    下一篇

MALAT1靶向调控miR-205与骨肉瘤侵袭的实验研究

  

  1. 421001  湖南衡阳  南华大学应用解剖与生殖医学研究所
  • 收稿日期:2017-11-21 修回日期:2018-02-23 出版日期:2018-05-31 发布日期:2018-06-07
  • 基金资助:
    湖南省教育厅基金资助项目(2016SJY18);湖南省自然科学基金资助项目(2018JJ3459)

Experimental study of MALAT1 targeting miR-205 and invasion of osteosarcoma 

  1. Key Lab of Clinical Anatomy & Reprodutive Medicine, University of South China,Hengyang 421001,China
  • Received:2017-11-21 Revised:2018-02-23 Online:2018-05-31 Published:2018-06-07

摘要: 目的   探讨人肺腺癌转移相关转录本1(MALAT1)与miR-205的关系,揭示MALAT1促进骨肉瘤发生发展的分子机制。方法   实时荧光定量PCR(QPCR)法检测骨肉瘤组织、癌旁正常组织、人成骨细胞(hFOB)以及骨肉瘤MG63、Sao-2细胞株中MALAT1和miR-205的表达;生物信息学及荧光素酶实验观察MALAT1对miR-205的靶向调控;miR-205 mimics转染Sao-2和MG63细胞后QPCR检测MALAT1表达, si-MALAT1转染Sao-2和MG63细胞后QPCR检测miR-205表达;miR-205 mimics和si-MALAT1分别转染MG63细胞,Transwell小室实验检测细胞侵袭能力,Western blotting检测MMP-2、MMP-9表达。结果   骨肉瘤组织、癌旁正常组织中MALAT1和miR-205表达量分别为4.7±0.6、2.6±0.08和2.2±0.09、3.7±0.3,差异有统计学意义(P<0.05);MG63、Sao-2细胞株中MALAT1和miR-205表达量分别为2.4±0.7、2.1±0.05和0.53±0.04、0.47±0.02,与hFOB中的0.9±0.01、0.82±0.04比较,差异有统计学意义(P<0.05);生物信息学及荧光素酶检测显示MALAT1序列中存在miR-205的3个互补序列,且两者存在靶向调控作用;转染si-MALAT1的Sao-2和MG63细胞中miR-205的表达量分别为3.4±0.7、3.8±0.6,对照组为1.4±0.5、1.0±0.1,差异有统计学意义(P<0.05);转染miR-205 mimics的Sao-2、MG63细胞中MALAT1的表达量分别为0.51±0.05、0.42±0.03,而对照组为1.5±0.7、1.28±0.4,差异有统计学意义(P<0.05);Transwell实验结果 显示miR-205 mimics组MG63细胞侵袭数为(28.52±3.68)个,低于miR-205 mimics与pMALAT1共转染组的(42.63±5.67)个,差异具有统计学意义(P<0.05);Western blotting结果 显示miR-205 mimics组MMP-2、MMP-9的表达量分别为0.41±0.02、0.49±0.04,显著低于miR-205与pMALAT1共转染组的0.73±0.01、0.80±0.05,差异具有统计学意义(P<0.05)。结论   MALAT1与miR-205之间存在双向抑制关系,MALAT1通过抑制miR-205的表达促进骨肉瘤细胞的侵袭。

关键词: 骨肉瘤, 人肺腺癌转移相关转录本1, miR-205, 侵袭

Abstract: Objective   To explore the relationship between MALAT1 and miR-205 and to reveal the molecular mechanism of MALAT1 to promote the occurrence and development of osteosarcoma. Methods   Real time fluorescence quantitative PCR (QPCR) was used to detect the expression of MALAT1 and miR-205 in osteosarcoma tissue, paracancerous normal tissue, human osteoblasts (hFOB), and MG63 and Sao-2 osteosarcoma cells. Bioinformatics and fluoro enzyme experimental was used to observe the targeting regulation of miR-205 by MALAT1. After transfection of miR-205 mimics to Sao-2 and MG63 cells, the expression of MALAT1 was detected by QPCR. After transfection of si-MALAT1 to Sao-2 and MG63 cells, the expression of miR-205 was detected by QPCR. MG63 cells were transfected by miR-205 mimics and si-MALAT1 respectively. The ability of invasion and metastasis was detected by Transwell compartment, and the expression of MMP-2 and MMP-9 was detected by Western blotting assay. Results  The expression level of MALATI and miR-205 in osteosarcoma tissue, paracancerous normal tissue were 4.7±0.6,2.6±0.08 and 2.2±0.09,3.7±0.3(P<0.05). The expression of MALAT1 and miR-205 in hFOB, MG63 cell line and Sao-2 cell line were 0.9±0.01, 2.4±0.7, 2.1±0.05 and 0.82±0.04, 0.53±0.04, 0.47±0.02(P<0.05). Bioinformatics and luciferase detection showed that there were three complementary sequences of miR-205 in the MALAT1 sequence, and both of them had a targeting regulation. The expression of miR-205 in Sao-2 and MG63 cells transfected with si-MALAT1 were 3.4±0.7 and 3.8±0.6, while that in the control group was 1.4±0.5 and 1±0.1. The difference was statistically significant (P<0.05). The expression of MALAT1 in Sao-2 and MG63 cells transfected with miR-205 mimics was 0.51 ± 0.05, 0.42 ± 0.03, while the control group was 1.5 ± 0.7, 1.28 ± 0.4. The difference was statistically significant (P<0.05). The number of MG63 cells invasion in miR-205 mimics group was 28.52 ± 3.68, which was lower than that in miR-205 and pMALAT1 co-transfection group (42.63 ± 5.67), the difference was statistically significant (P<0.05). The expression levels of MMP-2 and MMP-9 in miR-205 mimics group were 0.41 ± 0.02, 0.49 ± 0.04, which were significantly lower than those in miR-205 and pMALAT1 co-transfection group, the difference was statistically significant (P<0.05). Conclusion  There is a bi-directional inhibition relationship between MALAT1 and miR-205, and MALAT1 promotes the invasion and metastasis of osteosarcoma cells by inhibiting the expression of miR-205.

Key words: Osteosarcoma, Metastasis-associated lung adenocarcinoma transcript 1(MALAT1), miR-205, Invasion

中图分类号: 

  • R738.6 
No related articles found!
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 刘锦;李贵新;马传香. 恶性黑色素瘤腹腔转移1例[J]. 临床肿瘤学杂志, 2009, 14(1): 96 .
[2] 石 玮1,华海清2,王兴华1. 放疗对肠屏障功能的影响及研究进展[J]. 临床肿瘤学杂志, 2009, 14(1): 89 .
[3] 王杰军,李 睿. NCCN成人癌痛临床实践指南解读[J]. 临床肿瘤学杂志, 2009, 14(1): 80 .
[4] 崔传亮,迟志宏,袁香庆,斯 璐,盛锡楠,郭 军. 重组人血管内皮抑制素联合化疗一线治疗晚期黑色素瘤的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 74 .
[5]

高亚杰1,关小倩1,杨海林1,张 阳2,欧阳学农3,杨建伟4,陈 焰5,徐建明6,赵宣良7,王宝成8,刘文超9,张贺龙10,南克俊11,王湘辉12

. 注射用左亚叶酸钙联合治疗晚期胃癌和结直肠癌的Ⅱ期临床研究[J]. 临床肿瘤学杂志, 2009, 14(1): 47 .
[6]  白秀丽1,马振刚1,李际君2. 紫杉醇联合卡培他滨治疗进展期胃癌的临床观察[J]. 临床肿瘤学杂志, 2009, 14(1): 68 .
[7] 徐卫国1,杨小青2,郝世柱1,宋纪宁1,张鹏东1,胡潺潺1,王文雅1. 大肠癌组织中Neuropilin-1的表达及其与肿瘤血管生成的相关性研究[J]. 临床肿瘤学杂志, 2009, 14(1): 29 .
[8] 许景艳1,欧阳建,章宜芬2,周荣富1,陈 兵1,张启国1,杨永公1,邵小雁1,徐 勇1,关朝阳1. 原发性肋骨血管肉瘤的诊治探讨[J]. 临床肿瘤学杂志, 2009, 14(1): 70 .
[9] 徐晓明1,唐金海1,刘万花2,郑凯尔2,秦建伟1,赵祥生1,张 彤3. 触诊阴性乳腺癌的定位方法与同期手术治疗[J]. 临床肿瘤学杂志, 2009, 14(1): 43 .
[10] 张艳玲,邹 岚,肖 红,黄海辉,谭崇富,阮志华,王 希,梁后杰,庞学利. 影像引导调强放射治疗鼻咽癌[J]. 临床肿瘤学杂志, 2009, 14(1): 51 .